The Diagnostic Yield of Chromosomal Microarray Analysis in Third-Trimester Fetal Abnormalities

Eyal Elron1,2,3,4, Idit Maya3,4, Noa Shefer-Averbuch2,3,4,5

  • 1Department of Neonatology, Schneider Children's Medical Center, Petah Tikva, Israel.

PubMed
Summary

Chromosomal microarray analysis (CMA) is valuable for third-trimester fetal anomalies, yielding 6.2% for significant copy number variations (CNVs). This method detects findings potentially missed by noninvasive prenatal testing (NIPT), highlighting the importance of genetic counseling.